START FREE TRIAL

Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off

Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...

Snowflake Acquires Observe AI: The Boldest Move In Cloud Observability Yet!

Snowflake (NYSE:SNOW) just made a quiet but intriguing move that could reshape how enterprises handle observability at scale. On...

Meta Acquires Manus: The Real Reason Behind Zuckerberg’s $2 Billion AI Gamble

Meta Platforms (NASDAQ:META) just made another bold AI move. In a deal reportedly valued north of $2 billion, Meta...

Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!

If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace Manufacturing (CAM) from Stanley Black &...

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

WBD Contested Takeover: The $100B Deal the Board May Walk Away From

The battle for Warner Bros. Discovery (NASDAQ:WBD) just escalated. Despite Paramount’s $30 all-cash hostile bid, WBD’s board is preparing...

2026 Tech M&A: Is ServiceNow + Armis The Start Of A $100B+ AI Deal Wave?

ServiceNow (NYSE:NOW) is reportedly in advanced talks to acquire cybersecurity firm Armis for roughly $7 billion, a potential deal...

APi Group CertaSite Acquisition Sparks Investor Debate

In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!

Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...

Mirum Bluejay Acquisition Unlocks Rare Disease Gold!

Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...

Paramount Warner Bros Takeover: $108B Gamble Unfolds

Just days after Netflix stunned Hollywood with a $72 billion deal to acquire the studio and streaming assets of...